Patents by Inventor Tatu Miettenen

Tatu Miettenen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substance for lowering high cholesterol level in serum and methods for preparing and using the same
    Patent number: 7691834
    Abstract: The invention relates to a substance which lowers LDL cholesterol levels in serum and which is fat soluble ?-sitostanol fatty acid ester, and to a method for preparing and using the same. The substance can be taken orally as a food additive, food substitute or supplement. A daily consumption of the ?-sitostanol ester in an amount between about 0.2 and about 20 g/day has been shown to reduce the absorption of biliary and endogenic cholesterol.
    Type: Grant
    Filed: August 11, 2005
    Date of Patent: April 6, 2010
    Assignee: Raisio Nutrition Ltd.
    Inventors: Tatu Miettenen, Hannu Vanhanen, Ingmar Wester
  • Substance for lowering high cholesterol level in serum and methods for preparing and using the same
    Patent number: 7002030
    Abstract: The invention relates to a substance which lowers LDL cholesterol levels in serum and which is fat soluble ?-sitostanol fatty acid ester, and to a method for preparing and using the same. The substance can be taken orally as a food additive, food substitute or supplement. A daily consumption of the ?-sitostanol ester in an amount between about 0.2 and about 20 g/day has been shown to reduce the absorption of biliary and endogenic cholesterol.
    Type: Grant
    Filed: October 6, 2003
    Date of Patent: February 21, 2006
    Assignee: Raisio Benecol Ltd.
    Inventors: Tatu Miettenen, Ingmar Wester, Hannu Vanhanen
  • Substance for lowering high cholesterol level in serum and methods for preparing and using the same
    Publication number: 20050272711
    Abstract: The invention relates to a substance which lowers LDL cholesterol levels in serum and which is fat soluble ?-sitostanol fatty acid ester, and to a method for preparing and using the same. The substance can be taken orally as a food additive, food substitute or supplement. A daily consumption of the ?-sitostanol ester in an amount between about 0.2 and about 20 g/day has been shown to reduce the absorption of biliary and endogenic cholesterol.
    Type: Application
    Filed: August 11, 2005
    Publication date: December 8, 2005
    Inventors: Tatu Miettenen, Hannu Vanhanen, Ingmar Wester
  • Substance for lowering high cholesterol level in serum and methods for preparing and using the same
    Publication number: 20040067921
    Abstract: The invention relates to a substance which lowers LDL cholesterol levels in serum and which is fat soluble &bgr;-sitostanol fatty acid ester, and to a method for preparing and using the same. The substance can be taken orally as a food additive, food substitute or supplement. A daily consumption of the &bgr;-sitostanol ester in an amount between about 0.2 and about 20 g/day has been shown to reduce the absorption of biliary and endogenic cholesterol.
    Type: Application
    Filed: October 6, 2003
    Publication date: April 8, 2004
    Applicant: Raisio Benecol Ltd.
    Inventors: Tatu Miettenen, Ingmar Wester, Hannu Vanhanen
  • Substance for lowering high cholesterol level in serum and methods for preparing and using the same
    Publication number: 20030134833
    Abstract: The invention relates to a substance which lowers LDL cholesterol levels in serum and which is fat soluble &bgr;-sitostanol fatty acid ester, and to a method for preparing and using the same. The substance can be taken orally as a food additive, food substitute or supplement. A daily consumption of the &bgr;-sitostanol ester in an amount between about 0.2 and about 20 g/day has been shown to reduce the absorption of biliary and endogenic cholesterol.
    Type: Application
    Filed: November 7, 2002
    Publication date: July 17, 2003
    Applicant: Raisio Benecol Ltd.
    Inventors: Tatu Miettenen, Ingmar Wester, Hannu Vanhanen
  • Substance for lowering high cholesterol level in serum and methods for preparing and using the same
    Patent number: 6544973
    Abstract: The invention relates to a substance which lowers LDL cholesterol levels in serum and which is fat soluble &bgr;-sitostanol fatty acid ester, and to a method for preparing and using the same. The substance can be taken orally as a food additive, food substitute or supplement. A daily consumption of the &bgr;-sitostanol ester in an amount between about 0.2 and about 20 g/day has been shown to reduce the absorption of biliary and endogenic cholesterol.
    Type: Grant
    Filed: November 16, 2000
    Date of Patent: April 8, 2003
    Assignee: Raisio Benecol Ltd.
    Inventors: Tatu Miettenen, Ingmar Wester, Hannu Vanhanen
  • Substance for lowering high cholesterol level in serum and methods for preparing and using the same
    Patent number: 6174560
    Abstract: The invention relates to a substance which lowers LDL cholesterol levels in serum and which is fat soluble &bgr;-sitostanol fatty acid ester, and to a method for preparing and using the same. The substance can be taken orally as a food additive, food substitute or supplement. A daily consumption of the &bgr;-sitostanol ester in an amount between about 0.2 and about 20 g/day has been shown to reduce the absorption of biliary and endogenic cholesterol.
    Type: Grant
    Filed: November 12, 1998
    Date of Patent: January 16, 2001
    Assignee: Raisio Benecol, Ltd.
    Inventors: Tatu Miettenen, Ingmar Wester, Hannu Vanhanen
  • Substance for lowering high cholesterol level in serum and methods for preparing and using the same
    Patent number: 5958913
    Abstract: The invention relates to a substance which lowers LDL cholesterol levels in serum and which is fat soluble .beta.-sitostanol fatty acid ester, and to a method for preparing and using the same. The substance can be taken orally as a food additive, food substitute or supplement. A daily consumption of the .beta.-sitostanol ester in an amount between about 0.2 and about 20 g/day has been shown to reduce the absorption of biliary and endogenic cholesterol.
    Type: Grant
    Filed: November 5, 1996
    Date of Patent: September 28, 1999
    Assignee: Raisio Benecol Ltd.
    Inventors: Tatu Miettenen, Hannu Vanhanen, Ingmar Wester